Phenylketonurias
"Phenylketonurias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).
Descriptor ID |
D010661
|
MeSH Number(s) |
C10.228.140.163.100.687 C16.320.565.100.766 C16.320.565.189.687 C18.452.132.100.687 C18.452.648.100.766 C18.452.648.189.687
|
Concept/Terms |
Phenylketonuria II- Phenylketonuria II
- Phenylketonuria IIs
- DHPR Deficiency
- DHPR Deficiencies
- Deficiencies, DHPR
- Deficiency, DHPR
- Dihydropteridine Reductase Deficiency Disease
- HPABH4C
- Hyperphenylalaninemia, Bh4-Deficient, C
- Dihydropteridine Reductase Deficiency
- Deficiencies, Dihydropteridine Reductase
- Deficiency, Dihydropteridine Reductase
- Dihydropteridine Reductase Deficiencies
- Reductase Deficiencies, Dihydropteridine
- Reductase Deficiency, Dihydropteridine
- Phenylketonuria Type 2
- Phenylketonuria Type 2s
- Phenylketonuria, Atypical
- Atypical Phenylketonuria
- Atypical Phenylketonurias
- Phenylketonurias, Atypical
- PKU, Atypical
- Atypical PKU
- Atypical PKUs
- PKUs, Atypical
- QDPR Deficiency
- Deficiencies, QDPR
- Deficiency, QDPR
- QDPR Deficiencies
- Quinoid Dihydropteridine Reductase Deficiency
- Deficiency Disease, Dihydropteridine Reductase
- Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To Dhpr Deficiency
Phenylketonuria I- Phenylketonuria I
- Phenylketonuria Is
- Deficiency Disease, Phenylalanine Hydroxylase, Severe
- Folling Disease
- Disease, Folling
- Folling's Disease
- Disease, Folling's
- Phenylketonuria, Classical
- Classical Phenylketonuria
- Classical Phenylketonurias
- Phenylketonurias, Classical
- PAH Deficiency
- Deficiencies, PAH
- Deficiency, PAH
- PAH Deficiencies
- Phenylalanine Hydroxylase Deficiency
- Deficiencies, Phenylalanine Hydroxylase
- Deficiency, Phenylalanine Hydroxylase
- Hydroxylase Deficiencies, Phenylalanine
- Hydroxylase Deficiency, Phenylalanine
- Phenylalanine Hydroxylase Deficiencies
- Phenylalanine Hydroxylase Deficiency Disease
- Phenylalanine Hydroxylase Deficiency Disease, Severe
- Deficiency Disease, Phenylalanine Hydroxylase
- Oligophrenia Phenylpyruvica
- Oligophrenia Phenylpyruvicas
- Phenylpyruvica, Oligophrenia
- Phenylpyruvicas, Oligophrenia
Hyperphenylalaninemia, Non-Phenylketonuric- Hyperphenylalaninemia, Non-Phenylketonuric
- Hyperphenylalaninemia, Non Phenylketonuric
- Hyperphenylalaninemias, Non-Phenylketonuric
- Non-Phenylketonuric Hyperphenylalaninemia
- Non-Phenylketonuric Hyperphenylalaninemias
|
Below are MeSH descriptors whose meaning is more general than "Phenylketonurias".
- Diseases [C]
- Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Brain Diseases, Metabolic [C10.228.140.163]
- Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
- Phenylketonurias [C10.228.140.163.100.687]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Metabolism, Inborn Errors [C16.320.565]
- Amino Acid Metabolism, Inborn Errors [C16.320.565.100]
- Phenylketonurias [C16.320.565.100.766]
- Brain Diseases, Metabolic, Inborn [C16.320.565.189]
- Phenylketonurias [C16.320.565.189.687]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Phenylketonurias [C18.452.132.100.687]
- Metabolism, Inborn Errors [C18.452.648]
- Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
- Phenylketonurias [C18.452.648.100.766]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- Phenylketonurias [C18.452.648.189.687]
Below are MeSH descriptors whose meaning is more specific than "Phenylketonurias".
This graph shows the total number of publications written about "Phenylketonurias" by people in UAMS Profiles by year, and whether "Phenylketonurias" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 2 | 0 | 2 | 2022 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2003 | 0 | 1 | 1 | 2002 | 1 | 0 | 1 | 1993 | 1 | 0 | 1 | 1989 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Phenylketonurias" by people in Profiles over the past ten years.
-
Waisbren SE, Christ SE, Bilder DA, Bjoraker KJ, Bolton S, Chamberlin S, Grant ML, Janzen DM, Katz R, Lubliner E, Martin A, McQueen K, Moshkovich O, Nguyen-Driver M, Shim S, Stefanatos AK, Wilkening G, Harding C. Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup. Mol Genet Metab. 2024 Sep-Oct; 143(1-2):108555.
-
Trefz F, Frauendienst-Egger G, Dienel G, Cannet C, Schmidt-Mader B, Haas D, Blau N, Himmelreich N, Spraul M, Freisinger P, Dobrowolski S, Berg D, Pilotto A. Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients. Mol Genet Metab. 2024 May; 142(1):108464.
-
Burton BK, Hermida ?, B?langer-Quintana A, Bell H, Bjoraker KJ, Christ SE, Grant ML, Harding CO, Huijbregts SCJ, Longo N, McNutt MC, Nguyen-Driver MD, Santos Pessoa AL, Rocha JC, Sacharow S, Sanchez-Valle A, Sivri HS, Vockley J, Walterfang M, Whittle S, Muntau AC. Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach. Mol Genet Metab. 2022 Sep-Oct; 137(1-2):114-126.
-
Bilder DA, Arnold GL, Dimmock D, Grant ML, Janzen D, Longo N, Nguyen-Driver M, Jurecki E, Merilainen M, Amato G, Waisbren S. Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria. Am J Med Genet A. 2022 03; 188(3):768-778.
-
Wan Z, Rosenbaum ER, Liu W, Song B, Yue X, Kong Y, Li T, Zhai Y, Ma Z, Cao Z. Benchmark Examination of Blood Amino Acids Patterns in Phenylketonuria Neonates and Young Children on Phenylalanine-Restricted Dietary Treatment. Fetal Pediatr Pathol. 2022 Jun; 41(3):443-450.
-
Dienel GA, Cruz NF. Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats. Neurochem Res. 2016 Feb; 41(1-2):16-32.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|